Cargando…
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
BACKGROUND: Nilotinib is a tyrosine kinase inhibitor approved by the Ministry of Food and Drug Safety for frontline and 2nd line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph(+) CML). This study aimed to confirm the safety and efficacy of nilotinib in routine clinical pr...
Autores principales: | Ahn, Seo-Yeon, Son, Sang Kyun, Lee, Gyu Hyung, Kim, Inho, Cheong, June-Won, Lee, Won Sik, Kim, Byung Soo, Jo, Deog-Yeon, Jung, Chul Won, Seong, Chu Myoung, Lee, Jae Hoon, Yuh, Young Jin, Kim, Min Kyoung, Ryoo, Hun-Mo, Park, Moo-Rim, Cho, Su-Hee, Kim, Hoon-Gu, Zang, Dae Young, Park, Jinny, Kim, Hawk, Lee, Seryeon, Kim, Sung-Hyun, Chang, Myung Hee, Lee, Ho Sup, Choi, Chul Won, Kwon, Jihyun, Lim, Sung-Nam, Oh, Suk-Joong, Joo, Inkyung, Kim, Dong-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242833/ https://www.ncbi.nlm.nih.gov/pubmed/35678158 http://dx.doi.org/10.5045/br.2022.2021137 |
Ejemplares similares
-
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea
por: Shin, Junghoon, et al.
Publicado: (2018) -
Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
por: Na, Yoo Jin, et al.
Publicado: (2021) -
Barbed versus conventional 2-layer continuous running sutures for laparoscopic vaginal cuff closure
por: Kim, Jin Hwi, et al.
Publicado: (2016) -
Posterior Inferior Cerebellar Artery Infarction Originating at C1-2 after C1-2 Fusion
por: Won, Donghyun, et al.
Publicado: (2019) -
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party
por: Kim, Da Jung, et al.
Publicado: (2017)